Women less likely to get care for potentially fatal heart condition
Women are less likely than men to be given treatment for a potentially fatal heart condition, according to a new analysis.
Researchers in the UK found women are 11% less likely to be referred to a hospital specialist after a diagnosis of the heart valve disease aortic stenosis.
Academics said the findings show 'inequities in management and care of this common and serious condition' after they also found differences in care among south Asian and black patients as well as those from poorer backgrounds.
Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness.
The condition is more common in elderly people.
It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery.
If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death.
The analysis suggests some people are less likely to receive this treatment.
Experts from England's University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England.
Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve.
Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods.
Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients.
South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre.
Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis.
'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice.
'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
3 hours ago
- Time Business News
SyntecBiofuel Plans to Open New Lab in Asia
Syntecbiofuel Strategic investment in microbial biofuel technology aims to accelerate Asia's clean energy transition and strengthen global supply chains SyntecBiofuel, a global leader in sustainable biofuel innovation, today announced the establishment of a new state-of-the-art research and development laboratory in Asia [location TBD, e.g., Singapore or South Korea]. This expansion underscores SyntecBiofuel's commitment to revolutionizing biofuel production through synthetic biology and scaling sustainable solutions tailored for the rapidly growing Asian market. The strategic move aligns with the region's accelerating focus on decarbonization and renewable energy adoption. The new lab will leverage Asia's abundant biomass feedstocks and foster collaboration with local academic institutions and industry partners to drive breakthroughs in microbial biofuel technology. 'Our mission is to bridge synthetic biology innovations with scalable biofuel solutions that meet global sustainability goals,' said [CEO Name], CEO of SyntecBiofuel. 'Asia's vibrant innovation ecosystem is pivotal in achieving net-zero targets worldwide, and this lab will serve as a catalyst for delivering affordable, carbon-neutral biofuels to one of the world's fastest-growing energy markets.' The lab's core research initiatives will focus on metabolic engineering, waste-to-fuel conversion technologies, and optimizing biofuel yield and efficiency. These efforts aim to reduce production costs and enable the deployment of sustainable aviation fuel (SAF) and bio-gasoline tailored for the Asian market. SyntecBiofuel plans to launch the facility by [expected opening date], with a hiring initiative to recruit leading scientists and engineers in bioenergy and synthetic biology. The company invites strategic partnerships with investors, policymakers, and green technology collaborators to accelerate the transition to a sustainable energy future. Founded in [Year], SyntecBiofuel is a UK-based clean technology company pioneering advanced biofuel solutions. Backed by multiple patents and successful commercial deployments, SyntecBiofuel delivers innovative, sustainable fuels that reduce carbon emissions and support the circular economy. Media Contact Get in Touch with SyntecBiofuel's Media Relations Team For all press inquiries, interview requests, or media partnerships, please contact: Follow Us Online Stay updated on the latest news, innovations, and events from SyntecBiofuel: TIME BUSINESS NEWS
Medscape
8 hours ago
- Medscape
Experts Suggest NHS Heart Risk Checks from Age 25
MANCHESTER — Cardiovascular health assessments should begin much earlier, focusing on lifetime risk rather than just their 10-year projections, experts said at the British Cardiovascular Society Annual Conference 2025. 'We are looking at cardiovascular risk assessment far too late', said Beverley Bostock, a Queen's nurse and president-elect of the Primary Care Cardiovascular Society (PCCS). Bostock was introducing a conference session titled '25 is the new 40: shifting the focus to lifetime risk'. Prevention Focus in NHS Strategy Derek Connolly, a consultant cardiologist in private practice in Birmingham, said he hoped this approach would be supported in England's 10 Year Health Plan for the NHS. 'There is going to be an enormous emphasis, we think, going forward, on preventive cardiology – and it's about time that that was the case', he said. Connolly said that the team behind the plan were 'very into prevention' and 'had done the math' on the potential benefits of well-known strategies such as lifestyle interventions. By addressing modifiable risk factors earlier and throughout the life course, 'they've worked out that if we do a lot of these things, not only do we save lives, but we save money, and we keep people in work and paying taxes', he said. Rising CVD Burden Recent data in the European Journal of Preventative Cardiology , highlighted during the session, projected a 90% increase in global cardiovascular disease (CVD) prevalence over the next 25 years. CVD-related deaths are expected to rise from 20.5 million in 2025 to 35.6 million in 2050 – a 73.4% increase in crude mortality. Current NHS Risk Assessments The NHS currently assesses 10-year CVD risk from age 40, repeating every 5 years until age 74. This is typically measured using the cardiovascular risk score (QRISK 2), embedded in GP consulting software, although QRISK 3 and QRISK lifetime offer greater predictive power. Jim Moore "CVD risk is predicated around a lifetime exposure to risk factors,' said Jim Moore, a recently retired GP with a special interest in cardiovascular medicine. 'Just modest changes in those risk factors — your lipid profile or blood pressure — can, we know independently, and in combination, improve your outcomes.' Moore, a past president of the PCCS, said 10-year calculators may underestimate risk in those under 40, even when significant risk factors are present. Lifetime calculators could be 'persuasive' tools in patient consultations, he argued, with results helping to steer discussions towards lifestyle changes and risk factor modifications. The key message, he said, was the need for a holistic approach, which was 'something that we really do not see routinely happening in my area within primary care'. Case for Earlier Screening Scott Murray, a consultant cardiologist at University Hospitals of Liverpool Group and former president of the British Association for Cardiovascular Prevention and Rehabilitation, made the case for assessing CV risk in people under 40. Scott Murray Modern lifestyles characterised by sedentary behaviour, poor dietary habits, and increasing stress were contributing to rising CVD in younger populations. 'We're seeing more obesity, insulin resistance, dyslipidaemia, and hypertension', Murray said. 'I like to think of it a bit like this: so, you've got your genetic predisposition – genetics loads the gun, and your environment pulls the trigger.' Murray proposed age 25 as a theoretical "sweet spot" for screening. 'There's a sort of lifestyle transition at age 25 into more independent adulthood, more able to potentially think about family responsibilities.' At age 25, most people have finished puberty and reached physiological maturity. Data suggests that starting CVD screening at this age would be cost-effective by maximising opportunities for lower-cost interventions, according to Murray. However, he acknowledged potential difficulties in engaging 25-year-olds when NHS health checks for over-40s have not reached hoped-for targets. Targeted Approach Laura Ormesher, a National Institute for Health and Care Research academic clinical lecturer at the University of Manchester, suggested that pregnancy could be an ideal time to educate younger women about lifestyle-related CVD risk. 'We know that adverse pregnancy outcomes increase the risk of cardiovascular disease, and I think we've got to make the most of that opportunity during the pregnancy,' she said. She added that the postnatal period — typically 'a little bit less complicated for women' — is a time when many felt 'empowered to try and improve their long-term health for their child and their family,' Ormesher added. Dr Sundhya Raman Dr Sundhya Raman, a lifestyle physician, acknowledged that universal health checks from age 25 might be too ambitious but supported a targeted strategy. 'Maybe we need to target the higher risk individuals with strong family histories of raised BMI,' she said. 'There is great potential for when you educate one person, you educate a family, you educate a community,' Raman added. Moore has received honoraria for participation in educational activities and advisory boards from AstraZeneca, Amarin, Boehringer Ingelheim, Eli Lilly and Company, Daiichi-Sankyo, Novartis and Medtronic. Raman acknowledged she was a founder of My Wellness Doctor and My Weight Loss Doctor Clinic . Murray declared being the founder and medical director for Venturi Cardiology but had no relevant conflicts of interest. Ormesher had no conflicts to declare.
Time Business News
8 hours ago
- Time Business News
Fast Relief from Sleepless Nights – Sleeping Pills with Next Day UK Delivery
Your entire life will suffer negative effects when you lack sleep because it destroys your mood and energy as well as your concentration and your ability to function during daylight hours. Among the many people experiencing sleep difficulties, you probably search for an effective and quick solution for better rest. The wide range of sleeping pills in the UK is now more available through trusted online pharmacies that provide next-day UK delivery. The waiting time for relief is now reduced because you receive it without delay. People throughout the UK benefit from buying sleeping pills online for next-day delivery which revolutionizes their management approach to insomnia and sleep-related disturbances. The purpose ofSleeping Pills UK is to assist patients in quickest sleep onset and optimal sleep duration resulting in improved quality rest. Multiple types of sleeping pills exist in the market and patients can obtain their medicines through both prescribed drug channels and no prescribed channels. Acute insomnia together with short-term sleep problems requires medical prescription of both Zopiclone and Zolpidem medications. These medications now constitute some of the most effective sleeping pills present in the UK market. The market provides over-the-counter products for individuals facing periodic sleep issues. The market offers two main types of medications including antihistamine and herb-based formulas suitable for those who prefer gentler treatments. When you do not sleep well, time becomes important. Waiting for several days to get help can worsen symptoms such as anxiety, poor concentration and low productivity. This is the day after the delivery of the UK. With this service you can buy UK Sleeping Pills and deliver them to the door within 24 hours. The facility and speed of buying online sleeping pills in the UK can make a big difference for someone suffering from back-to-back sleepless nights. Getting rapid relief means avoiding long -term mental and physical consequences of ongoing shortage of sleep. Safety is needed when choosing to Buy Sleeping Pills UK. Always look for licensed UK-based online pharmacies registered with medicines and health product regulation agency (MHRA). These sites will usually need to fill out a medical questionnaire, which will be reviewed by a qualified health care provider. Avoid websites that provide sleeping pills without any kind of consultation or prescription. These sites can sell false or irregular medicines that may be dangerous to your health. When you use a valid supplier, your consultation, approval and distribution process is handled by professionals and safe. If you are looking for the best sleeping pills available in the UK, Zopiclone and Zolpidem are two of the most prescribed drugs for insomnia. Zopiclone is often available at 7.5 mg tablet and is known to help individuals quickly sleep and sleep at night. Zolpidem, a more widespread drug, has a similar effect and is often preferred for its little life, which reduces the possibility of growing the next day. In addition to these recipe options, natural sleep aids such as melatonin-based supplements, valerian root or antihistamine can also be purchased for Miller symptoms. The opportunity to buy online sleeping pills in the UK provides many benefits. First of all, you save time by avoiding commercial appointments and pharmacy visits. Second, online pharmacies often offer better prices and proper packaging. Third, the next day's delivery lets you address immediate sleep problems without delay. You can also review different product options, customers can read reviews and get medical guidance without leaving home. This availability has purchased the Go-to method for many people who relieve insomnia and other sleep problems in the UK. Click Here to Buy Sleeping Pills Online at UK Sleep Care. It is important to consider the cause of your sleeplessness before you start taking some sleeping pills the UK. Stress, diet, irregular sleep routine and mental health disorders can all play a role in troubled sleep. While the drug can provide immediate relief, long -term solutions often include lifestyle changes. It is recommended to use sleeping pills for short -term support while improving sleep hygiene. This includes maintaining a steady sleep, reducing screen time before bedtime, limiting caffeine intake in the evening and creating a cool sleep environment. Sleep pills can be very effective for those who need quick relief from sleep evenings. However, they are not for everyone. People with a history of drug addiction, breathing problems or some chronic conditions should consult a doctor before using them. Fortunately, when you buy the UK from a well-known online pharmacy, you will get the right medical guidance to ensure that the drug is right for you. If you have tried to change natural means and lifestyle without success, a small course of prescribed British sleep pills can help reset the sleep cycle and improve your overall health. Sleep is important for your physical and mental welfare. Lack of sleep can lead to chronic fatigue, weak immune function, irritability and even depression. This is why quick access to the best sleeping pills with the next day's delivery is more than a luxury – this is a requirement for many. Being able to buy online sleeping pills in the UK gives you control of your sleep health supported health. Whether you work with jet intervals, stress or ongoing insomnia, access to effective drug the next day means that you no longer need to suffer through endless sleep evenings. For people struggling with poor sleep, quick access is important for effective treatment. Thanks to the Internet, it is much easier to Buy Sleeping Pills UK, and has been distributed the following day. Whether you are looking for treatment or prescription solutions, reliable online pharmacies in the UK provide safe, practical and professional service. Sleep should not be a luxury. If you are ready to control your nights and restore your days, consider the facility to buy online sleeping pills in the UK with delivery in the UK the following day. TIME BUSINESS NEWS
